RHO and melanoma: Study by Foda et al. (2025) Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: implications for the involvement of pirin, highlighting the significance of the Rho/MRTF pathway in the development of melanoma drug resistance (Foda et al., 2025).